BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26724171)

  • 1. Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export.
    Parks SK; Cormerais Y; Marchiq I; Pouyssegur J
    Mol Aspects Med; 2016; 47-48():3-14. PubMed ID: 26724171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and cellular metabolism in tumour pathophysiology.
    Parks SK; Cormerais Y; Pouysségur J
    J Physiol; 2017 Apr; 595(8):2439-2450. PubMed ID: 28074546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
    Ganapathy V; Thangaraju M; Prasad PD
    Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and distribution of facilitative glucose (GLUTs) and monocarboxylate/H+ (MCTs) transporters in rat olfactory epithelia.
    Nunez-Parra A; Cortes-Campos C; Bacigalupo J; Garcia Mde L; Nualart F; Reyes JG
    Chem Senses; 2011 Nov; 36(9):771-80. PubMed ID: 21677031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting pH regulating proteins for cancer therapy-Progress and limitations.
    Parks SK; Pouysségur J
    Semin Cancer Biol; 2017 Apr; 43():66-73. PubMed ID: 28137473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
    Li X; Yu X; Dai D; Song X; Xu W
    Oncotarget; 2016 Apr; 7(17):23141-55. PubMed ID: 27009812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor hypoxia and metabolism -- towards novel anticancer approaches.
    Chiche J; Ricci JE; Pouysségur J
    Ann Endocrinol (Paris); 2013 May; 74(2):111-4. PubMed ID: 23597945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific transcriptional regulation of monocarboxylate transporters (MCTs) during short-term hypoxia in zebrafish (Danio rerio).
    Ngan AK; Wang YS
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Dec; 154(4):396-405. PubMed ID: 19709642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
    Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; Jurmeister S; Ramos-Montoya A; Asim M; Tran M; Oliveira E; Lobo da Cunha A; Maximo V; Baltazar F; Neal DE; Fryer LG
    J Pathol; 2015 Aug; 236(4):517-30. PubMed ID: 25875424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting lactate transport suppresses in vivo breast tumour growth.
    Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; Longatto-Filho A; Paredes J; Baltazar F; Pinheiro C
    Oncotarget; 2015 Aug; 6(22):19177-89. PubMed ID: 26203664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells.
    Yoshida GJ
    Metabolites; 2021 Jan; 11(1):. PubMed ID: 33401672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.
    Chiche J; Brahimi-Horn MC; Pouysségur J
    J Cell Mol Med; 2010 Apr; 14(4):771-94. PubMed ID: 20015196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas.
    Miranda-Gonçalves V; Reis RM; Baltazar F
    Curr Cancer Drug Targets; 2016; 16(5):388-99. PubMed ID: 26694251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporters as targets and mediators in cancer therapy response.
    Baltazar F; Pinheiro C; Morais-Santos F; Azevedo-Silva J; Queirós O; Preto A; Casal M
    Histol Histopathol; 2014 Dec; 29(12):1511-24. PubMed ID: 24921258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
    Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
    Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
    Airley RE; Mobasheri A
    Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of pH regulators in the diagnosis, prognosis and treatment of cancer.
    Granja S; Tavares-Valente D; Queirós O; Baltazar F
    Semin Cancer Biol; 2017 Apr; 43():17-34. PubMed ID: 28065864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
    Shi Y; Liu S; Ahmad S; Gao Q
    Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.